Methadone intermediate
![]() | This article needs additional citations for verification. (December 2018) |
![]() | |
Clinical data | |
---|---|
Routes of administration | N/A |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.004.324 ![]() |
Chemical and physical data | |
Formula | C19H22N2 |
Molar mass | 278.399 g·mol−1 |
3D model (JSmol) | |
| |
|
Methadone intermediate is a methadone precursor scheduled by UN Single Convention on Narcotic Drugs. It is a Schedule II Narcotic controlled substance in the United States and has an ACSCN of 9254. The 2014 annual manufacturing quota was 32 875 kilos.[1]
See also[]
- Moramide intermediate
- Pethidine intermediate A
- Pethidine intermediate B (norpethidine)
- Pethidine intermediate C (pethidinic acid)
References[]
Categories:
- Drugs not assigned an ATC code
- Synthetic opioids
- Drug rehabilitation
- Dimethylamino compounds
- Analgesic stubs